Skip to search formSkip to main contentSkip to account menu

Edex

Known as: Prostavasin 
National Institutes of Health

Related topics

Related topics

4 relations
1 ML Alprostadil 0.02 MG/ML Cartridge [Edex]Prostin VRViridal

Broader (1)

Alprostadil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
[The role of intra-operative Prostavasin application during crural bypass surgery].
INTRODUCTION The aim of this study was to evaluate the role of intra-operative Prostavasin application during crural bypass… 
Review
2003
Review
2003
Aktuelle Diagnostik und Therapie der nicht okklusiven mesenterialen Ischämie
Purpose Non-occlusive mesenteric ischemia (NOMI) is a life threatening disease. Therapy and prognosis depend upon the length of… 
2002
2002
Die Anwendung von Prostaglandin E1 bei mikrovaskulären Rekonstruktionen der oberen Extremität nach Akuttraumen
ZusammenfassungDie operative Versorgung zum Erhalt einer traumatisch geschädigten Extremität mit Unterbrechung der Gef… 
2000
2000
Wirksamkeit und Verträglichkeit von Prostaglandin E1 bei kurzen Infusionszeiten. Eine kontrollierte Studie bei Patienten mit Claudicatio intermittens
Zusammenfassung Die empfohlene Infusionszeit für die i.v.-Prostaglandin E1 (PGE1)-Therapie beträgt dosisabhängig 2 bzw. 3 h. In… 
1999
1999
Multizentrische Studie zur Lebensqualität nach i. v. Prostavasin®-Therapie im Stadium IV der AVK
1997
1997
Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudication.
BACKGROUND Increasingly and justifiably, clinical studies are now being expected to investigate the influence of therapeutic… 
1994
1994
[Results of intra-arterial administration of PGE1 prostaglandin].
On the basis of own clinical material the results are presented of intra-arterial administration of PGE1 prostaglandin… 
1993
1993
Experimental assessment of thrombogenicity in vascular prostheses before and during prostaglandin E1 treatment.
1989
1989
Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
The efficacy and tolerability of intra-arterial and intravenous PGE1 infusions in patients with occlusive arterial disease [OAD… 
1989
1989
Experience with PGE1 in patients with postoperative trashfoot.
Within a 16 years observation period a trash phenomenon was seen in 15 patients. In 13 of these patients it occurred as a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)